Zobrazeno 1 - 10
of 39
pro vyhledávání: '"N, Cacciari"'
Autor:
C Pizzirani, M Lenzi, N Cacciari, Claudio Zamagni, A. Bernardi, M Pagliaro, S Minichillo, P Stieber, Elena Barbieri, Sara Quercia, S Tomasini, A Fini, Luigi Mariani, Massimo Gion, Daniela Rubino
Publikováno v:
Cancer Research. 77:OT3-05
Background: Current guidelines for BC surveillance in asymptomatic pts recommend annual mammography and periodical physical examination. These recommendations arise from two trials conducted in the 1980's: since then no other randomized controlled tr
Autor:
M Carapelle, M Lenzi, S Tomasini, Richard P. Baum, Massimo Gion, Petra Stieber, Claudio Zamagni, Ralph M. Wirtz, C Pizzirani, Luigi Mariani, M Pagliaro, A. Bernardi, S Toracchio, M Cubelli, Sara Quercia, Stefano Fanti, Elena Barbieri, N Cacciari, Daniela Rubino
Publikováno v:
Annals of Oncology. 28:vi81
Autor:
Franco Pannuti, Claudio Zamagni, L. Zanichelli, B. Bellanova, F. Vecchi, Andrea Martoni, Elena Strocchi, N. Cacciari
Publikováno v:
European Journal of Cancer. 31:1615-1621
Serum levels of carcinoembryonic antigen (CEA), mucin-like carcinoma-associated antigen (MCA), CA 15.3 and CA 549 were concurrently assayed in patients with metastatic breast cancer. Overall sensitivity in detecting metastatic breast cancer (201 pts)
Publikováno v:
The International Journal of Biological Markers. 7:217-221
CA-549 serum levels were assessed in 288 patients, 156 with early breast cancer (after surgery) and 132 with advanced breast cancer. CA-549 was abnormal (> 12 U/ml) in 25/156 patients (16%) without clinical signs of disease after surgery (median 9 U/
Publikováno v:
European journal of gynaecological oncology. 21(1)
A phase I study was performed in order to evaluate the tolerability of the combination of fixed doses of carboplatin and paclitaxel and escalated doses of topotecan as first line chemotherapy for advanced epithelial ovarian cancer. Three stage III an
Publikováno v:
European journal of gynaecological oncology. 20(1)
From 1981 to 1992, 230 previously chemotherapy-untreated epithelial ovarian cancer patients (Stages IIb-III or IV) received platinum-based polychemotherapy at our Division. In this presentation, time to progression and overall survival rates were ret
Publikováno v:
Frontiers in bioscience : a journal and virtual library. 2
Majority of ovarian cancer patients have advanced disease (stage III or IV) at diagnosis and the prognosis of these patients is poor in spite of aggressive surgery. Therefore chemotherapy has gained a fundamental role in the therapeutic approach of o
Autor:
A. Silva, G. Robustelli Della Cuna, L. Pavesi, Carlo Maurizio Camaggi, Elena Strocchi, M. Tedeschi, Claudio Zamagni, N. Cacciari, Andrea Martoni, Franco Pannuti
Publikováno v:
Cancer chemotherapy and pharmacology. 36(4)
The bioequivalence of two megestrol acetate formulations, 160-mg "tablets" and 160-mg "sachets," was investigated in a single-dose, open-label, balanced-for-sequence cross-over study involving 12 advanced-cancer patients. The observed plasma megestro
Autor:
N. Cacciari, H.A. Chaudri, Andrea Martoni, Christian Pfister, D. Alberti, Nicola Fazio, Franco Pannuti, M. G. Morritti, F. de Braud, G. Lelli, Claudio Zamagni
Publikováno v:
European Journal of Cancer. 35:S292-S293
Autor:
M. Taffurelli, Daniele Santini, A Martoni, S. Fanti, A. Bernardi, C. Zamagni, M. Rosati, Sara Quercia, F. Massari, N Cacciari
Publikováno v:
European Journal of Cancer Supplements. 6:62